-

Thermo Fisher Scientific Digital Transformation Strategy Analysis Report 2025: Accelerators, Incubators, and Other Innovation Programs - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Enterprise Tech Ecosystem Series: Thermo Fisher Scientific - 2025" company profile has been added to ResearchAndMarkets.com's offering.

The report offers detailed information and insights into Thermo Fisher’s technology activities, highlighting its digital transformation strategies and innovation programs. It provides an overview of key technology initiatives, including partnerships, product launches, investments, and acquisitions, along with insights into each initiative’s technology theme, objectives, and benefits. Additionally, the report includes details on estimated ICT budgets.

Thermo Fisher Scientific Inc. (Thermo Fisher) is an American company offering a variety of products, solutions and services to the pharmaceuticals, biotechnology, hospitals, and clinical diagnostic labs industries. Its products and services are also widely used by research institutions, government agencies, and universities. Thermo Fisher reports its business performance through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products & Biopharma Services.

The Life Sciences Solutions segment offers reagents, instruments and consumables for customers in pharmaceuticals and medical research industries. The Analytical Instruments segment offers chromatography solutions, electron microscopes, and mass spectrometers. The Specialty Diagnostics segment offers culture media, reagents, diagnostic test kits, and instruments. The Laboratory Products and Biopharma Services segment offers lab consumables, equipment and chemicals. Major brands of the company are Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Labs Services, Patheon, PPD, and Gibco.

Scope

  • The report provides insights into the company's tech activities, including its digital transformation strategies, its innovation programs, its technology initiatives, its investments and its acquisitions.

Reasons to Buy

  • Gain insights into Thermo Fisher's tech operations.
  • Gain insights into its tech strategies and innovation initiatives.
  • Gain insights into its technology themes under focus.
  • Gain insights into various product launches, partnerships, investments and acquisitions

Key Topics Covered:

  • Thermo Fisher's Overview
  • Thermo Fisher's Digital Transformation Strategy
  • Thermo Fisher's Technology Focus
  • Thermo Fisher's Technology Initiatives
  • Thermo Fisher's Tech Investments
  • Thermo Fisher's Tech Acquisitions
  • Thermo Fisher's Tech Ecosystem
  • Thermo Fisher's ICT Budget and Contracts
  • Thermo Fisher's Senior Management
  • Thermo Fisher's Thematic Scorecard

A selection of companies mentioned in this report includes, but is not limited to:

  • Mirai Bio
  • Evalueserve
  • Genoox
  • Medidata
  • MSAID
  • Cellular Origins
  • Multiply Labs
  • CytoReason
  • CorEvitas LLC

For more information about this company profile visit https://www.researchandmarkets.com/r/oa740

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Industry:

Research and Markets

Release Versions
English

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Blockchain and Non-Fungible Tokens new Technologies and the Relevant Law Training Course: Core Principles, Smart Contracts, NFTs, and Decentralized Finance Explained (Online Event: May 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Blockchain and Non-Fungible Tokens: Understanding new Technologies and the Relevant Law Training Course (May 20, 2026)" training has been added to ResearchAndMarkets.com's offering. Blockchain is a new technology that could potentially have major impacts in a wide range of industries. It has the potential to dramatically change how business is conducted - but there is no one central authority controlling blockchain, everyone has access to the same information. Are...

Writing Clinical Research with Integrity Training Course: Principles of Medical and Scientific Writing, Including Ethical Standards, Data Integrity, and Plagiarism Prevention (Online: Apr 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Writing Clinical Research with Integrity Training Course (Apr 20, 2026)" training has been added to ResearchAndMarkets.com's offering. This course covers key principles of medical and scientific writing, including ethical standards, data integrity, and plagiarism prevention. Participants will learn how to tailor content for various audiences, structure documents (e.g., manuscripts, protocols), and adhere to writing standards such as clarity, consistency, and correc...

In-Vitro Diagnostic Regulation (EU) 2017/746 Introduction Training Course (Online Event: Apr 16th - Apr 17th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (Apr 16th - Apr 17th, 2026)" training has been added to ResearchAndMarkets.com's offering. The In-Vitro Diagnostic Regulation (EU) 2017/746, which came into force in May 2017 with a transition period of five years, is intended to strengthen the current approval system for in-vitro diagnostics and makes substantial changes to the existing IVD Directive (98/79/EC) legislation. The Regulation in...
Back to Newsroom